|
Volumn 69, Issue 3, 2001, Pages 1574-1580
|
Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALBENDAZOLE;
CHOLERA TOXIN B SUBUNIT;
CHOLERA VACCINE;
CHOLERA VACCINE CVD 103HGR;
GAMMA INTERFERON;
INTERLEUKIN 2;
PLACEBO;
UNCLASSIFIED DRUG;
ADULT;
ARTICLE;
ASCARIASIS;
ASCARIS LUMBRICOIDES;
CHOLERA;
CLINICAL TRIAL;
COMORBIDITY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOKINE PRODUCTION;
DOUBLE BLIND PROCEDURE;
HUMAN;
HUMAN CELL;
HUMAN EXPERIMENT;
IMMUNE RESPONSE;
IMMUNOMODULATION;
NORMAL HUMAN;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
VACCINATION;
ADULT;
ALBENDAZOLE;
ANIMALS;
ANTHELMINTICS;
ANTIGENS, HELMINTH;
ASCARIASIS;
ASCARIS LUMBRICOIDES;
CHOLERA;
CHOLERA TOXIN;
CHOLERA VACCINES;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
INTERFERON TYPE II;
INTERLEUKIN-2;
LEUKOCYTES, MONONUCLEAR;
MALE;
VACCINATION;
|
EID: 0035118557
PISSN: 00199567
EISSN: None
Source Type: Journal
DOI: 10.1128/IAI.69.3.1574-1580.2001 Document Type: Article |
Times cited : (188)
|
References (38)
|